Director/PDMR Shareholding

Baronsmead Second Venture Trust PLC
26 September 2024
 

26 September 2024

 

 

BARONSMEAD SECOND VENTURE TRUST PLC

("THE COMPANY")

 

The Company was notified on 25 September that Graham McDonald, Non-executive Director of the Company, acquired 1,595 Ordinary shares of 10 pence each in the capital of the Company, through participation in the Company's Dividend Reinvestment Plan, at a price of 57.60 pence per Ordinary share. As a result of this purchase, Mr McDonald's aggregate holding of shares in the Company is 54,749 Ordinary shares, representing 0.01% of the Company's issued share capital.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graham McDonald

2.

Reason for the notification

b)

Position / status

Non-Executive Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Baronsmead Second Venture Trust plc

b)

LEI

2138008D3WUMF6TW8C28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.10 each

 

 

ISIN: GB0030028103

b)

Nature of the transaction

Acquisition of shares through participation in the Dividend Reinvestment Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.5760

1,595

d)

Aggregated information

Aggregated volume

Price

N/A - single transaction

e)

Date of the transaction

17/09/2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

For further information please contact:

 

Baronsmead VCT Investor Relations

 

020 7382 0999

 

baronsmeadvcts@greshamhouse.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings